Alphatec vs Novocure
Alphatec reported revenue of $764 million in fiscal 2025, 1.2 times Novocure's $655 million in fiscal 2025. Alphatec's revenue grew 24.9% in its latest year, and Novocure's grew 8.3%. Alphatec had an operating margin of -10.8%, against -23.5% at Novocure. Free cash flow was $3 million at Alphatec and −$76 million at Novocure.
Side by side
| Alphatec | Novocure | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $764M | $655M |
| Revenue growth | 24.9% | 8.3% |
| Revenue growth a year, last 5 years | 39.5% | 5.8% |
| Gross margin | 69.6% | 74.5% |
| Operating margin | −10.8% | −23.5% |
| Net margin | −18.8% | −20.8% |
| Free cash flow | $3M | −$76M |
| Free cash flow margin | 0.4% | −11.6% |
| Return on capital | −14.3% | −33.0% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 5.0% | 3.4% |
| Last close | $7.07 | $11.83 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | — | sold $2.9 million |
| Piotroski F-score | 5 of 9 | 4 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
AlphatecNovocure
Operating margin
Percent of revenue
AlphatecNovocure
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AlphatecNovocure
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Alphatec and Novocure pages.